Case Study Phase One A biotechnology firm preparing to launch its first specialty drug The Bridge from Lab to Launch How a carefully tuned strategy launched a brand new drug, and transformed a cutting edge research firm into a market ready biotech company Phase I: Designing an Integrated Launch Plan With potential FDA approval still a year and a half away, it might have appeared that this emerging biotechnology company had plenty of time to e

Join for free to read